• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻女性浸润性乳腺癌中血管生成素样蛋白4和胰岛素样生长因子-1的表达

Angiopoietin-Like Protein 4 and Insulin-Like Growth Factor-1 Expression in Invasive Breast Carcinoma in Young Women.

作者信息

Kamaludin Zaleha, Siddig Alaa, Yaacob Najib Majdi, Lam Alfred K, Rahman Wan Faiziah Wan Abdul

机构信息

Department of Pathology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kelantan 16150, Malaysia.

Unit of Biostatistics and Research Methodology, Health Campus, Universiti Sains Malaysia, Kelantan 16150, Malaysia.

出版信息

Pathophysiology. 2022 Jan 13;29(1):9-23. doi: 10.3390/pathophysiology29010002.

DOI:10.3390/pathophysiology29010002
PMID:35366286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8955684/
Abstract

Biomarker identification is imperative for invasive breast carcinoma, which is more aggressive and associated with higher mortality and worse prognosis in younger patients (<45 years) than in older patients (>50 years). The current study aimed to investigate angiopoietin-like protein 4 (ANGPTL4) and insulin-like growth factor-1 (IGF-1) protein expression in breast tissue from young patients with breast carcinoma. Immunohistochemical staining was applied in formalin-fixed, paraffin-embedded samples of breast carcinoma tissue from young patients aged <45 years at the time of diagnosis. Both proteins were expressed in the majority of cases. The highest frequency of positive ANGPTL4 and IGF-1 expression was observed in the luminal A subtype, whereas the HER2-overexpression subtype exhibited the lowest expression frequency for both proteins. There was no significant association between ANGPTL4 (p = 0.897) and IGF-1 (p = 0.091) expression and molecular subtypes of breast carcinoma. The histological grade was a significant predictor of ANGPTL4 expression (grade 1 vs. grade 3, adjusted odds ratio = 12.39, p = 0.040). Therefore, ANGPTL-4 and IGF-1 expressions are common in young breast carcinoma tissue. There is a potential use of them as biomarkers in breast carcinoma.

摘要

生物标志物的鉴定对于浸润性乳腺癌至关重要,浸润性乳腺癌更具侵袭性,与年轻患者(<45岁)相比,老年患者(>50岁)的死亡率更高且预后更差。本研究旨在调查年轻乳腺癌患者乳腺组织中血管生成素样蛋白4(ANGPTL4)和胰岛素样生长因子-1(IGF-1)的蛋白表达情况。对诊断时年龄<45岁的年轻患者的福尔马林固定、石蜡包埋的乳腺癌组织样本进行免疫组织化学染色。在大多数病例中均检测到这两种蛋白的表达。ANGPTL4和IGF-1阳性表达频率最高的是管腔A型,而HER2过表达型这两种蛋白的表达频率最低。ANGPTL4(p = 0.897)和IGF-1(p = 0.091)的表达与乳腺癌分子亚型之间无显著关联。组织学分级是ANGPTL4表达的显著预测指标(1级与3级,校正比值比= 12.39,p = 0.040)。因此,ANGPTL-4和IGF-1在年轻乳腺癌组织中表达常见。它们有可能作为乳腺癌的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b1/8955684/6788e5273c0a/pathophysiology-29-00002-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b1/8955684/aaee62e438ea/pathophysiology-29-00002-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b1/8955684/a10f4c803f7c/pathophysiology-29-00002-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b1/8955684/8da607bf8312/pathophysiology-29-00002-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b1/8955684/5fb991425300/pathophysiology-29-00002-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b1/8955684/6788e5273c0a/pathophysiology-29-00002-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b1/8955684/aaee62e438ea/pathophysiology-29-00002-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b1/8955684/a10f4c803f7c/pathophysiology-29-00002-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b1/8955684/8da607bf8312/pathophysiology-29-00002-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b1/8955684/5fb991425300/pathophysiology-29-00002-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b1/8955684/6788e5273c0a/pathophysiology-29-00002-g005.jpg

相似文献

1
Angiopoietin-Like Protein 4 and Insulin-Like Growth Factor-1 Expression in Invasive Breast Carcinoma in Young Women.年轻女性浸润性乳腺癌中血管生成素样蛋白4和胰岛素样生长因子-1的表达
Pathophysiology. 2022 Jan 13;29(1):9-23. doi: 10.3390/pathophysiology29010002.
2
Angiopoietin-like protein 3 and 4 expression 4 and their serum levels in hepatocellular carcinoma.血管生成素样蛋白3和4的表达及其在肝细胞癌中的血清水平。
Cytokine. 2017 Aug;96:75-86. doi: 10.1016/j.cyto.2017.03.006. Epub 2017 Mar 31.
3
ANGPTL4 overexpression is associated with progression and poor prognosis in breast cancer.血管生成素样蛋白4(ANGPTL4)过表达与乳腺癌的进展及不良预后相关。
Oncol Lett. 2020 Sep;20(3):2499-2505. doi: 10.3892/ol.2020.11768. Epub 2020 Jun 24.
4
Significance of Tissue Expression and Serum Levels of Angiopoietin-like Protein 4 in Breast Cancer Progression: Link to NF-κB /P65 Activity and Pro-Inflammatory Cytokines.血管生成素样蛋白4的组织表达及血清水平在乳腺癌进展中的意义:与核因子κB/P65活性及促炎细胞因子的关联
Asian Pac J Cancer Prev. 2015;16(18):8579-87. doi: 10.7314/apjcp.2015.16.18.8579.
5
Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study.阿尔及利亚女性分子乳腺癌亚型的分布及其与临床和肿瘤特征的相关性:一项基于人群的研究。
Breast Dis. 2015;35(2):95-102. doi: 10.3233/BD-150398.
6
Characterisation of GATA3 expression in invasive breast cancer: differences in histological subtypes and immunohistochemically defined molecular subtypes.浸润性乳腺癌中GATA3表达的特征:组织学亚型和免疫组化定义的分子亚型的差异
J Clin Pathol. 2017 Nov;70(11):926-934. doi: 10.1136/jclinpath-2016-204137. Epub 2017 Apr 20.
7
Comparisons of p53, KI67 and BRCA1 expressions in patients with different molecular subtypes of breast cancer and their relationships with pathology and prognosis.不同分子亚型乳腺癌患者中p53、KI67和BRCA1表达的比较及其与病理和预后的关系。
J BUON. 2019 Nov-Dec;24(6):2361-2368.
8
IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.IMP3是三阴性浸润性乳腺癌的一种新型生物标志物,与更具侵袭性的表型相关。
Hum Pathol. 2009 Nov;40(11):1528-33. doi: 10.1016/j.humpath.2009.05.005. Epub 2009 Aug 19.
9
Clinicopathological significance of insulin-like growth factor-1 receptor expression in breast cancer.乳腺癌中胰岛素样生长因子-1 受体表达的临床病理意义。
Ann Ital Chir. 2020;91:583-591.
10
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.《卡罗来纳乳腺癌研究中的种族、乳腺癌亚型与生存率》
JAMA. 2006 Jun 7;295(21):2492-502. doi: 10.1001/jama.295.21.2492.

引用本文的文献

1
The role of ANGPTL4 in cancer: A meta-analysis of observational studies and multi-omics investigation.血管生成素样蛋白4在癌症中的作用:观察性研究的荟萃分析和多组学调查
PLoS One. 2025 Apr 15;20(4):e0320343. doi: 10.1371/journal.pone.0320343. eCollection 2025.
2
Potential role of ANGPTL4 in cancer progression, metastasis, and metabolism: a brief review.ANGPTL4 在癌症进展、转移和代谢中的潜在作用:简要综述。
BMB Rep. 2024 Aug;57(8):343-351. doi: 10.5483/BMBRep.2024-0082.

本文引用的文献

1
Role of the IGF-1 Axis in Overcoming Resistance in Breast Cancer.胰岛素样生长因子-1轴在克服乳腺癌耐药中的作用
Front Cell Dev Biol. 2021 Mar 22;9:641449. doi: 10.3389/fcell.2021.641449. eCollection 2021.
2
ANGPTL4 overexpression inhibits tumor cell adhesion and migration and predicts favorable prognosis of triple-negative breast cancer.ANGPTL4 过表达抑制肿瘤细胞黏附和迁移,并预测三阴性乳腺癌的预后良好。
BMC Cancer. 2020 Sep 14;20(1):878. doi: 10.1186/s12885-020-07343-w.
3
ANGPTL4 overexpression is associated with progression and poor prognosis in breast cancer.
血管生成素样蛋白4(ANGPTL4)过表达与乳腺癌的进展及不良预后相关。
Oncol Lett. 2020 Sep;20(3):2499-2505. doi: 10.3892/ol.2020.11768. Epub 2020 Jun 24.
4
Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with ∼430 000 women.胰岛素样生长因子-1、胰岛素样生长因子结合蛋白-3 与乳腺癌风险:近 43 万名女性的观察性和孟德尔随机化分析。
Ann Oncol. 2020 May;31(5):641-649. doi: 10.1016/j.annonc.2020.01.066. Epub 2020 Mar 10.
5
Role of the growth hormone-IGF-1 axis in cancer.生长激素-胰岛素样生长因子-1轴在癌症中的作用。
Expert Rev Endocrinol Metab. 2011 Jan;6(1):71-84. doi: 10.1586/eem.10.73.
6
Revisiting the IGF-1R as a breast cancer target.重新审视胰岛素样生长因子-1受体作为乳腺癌靶点
NPJ Precis Oncol. 2017;1. doi: 10.1038/s41698-017-0017-y. Epub 2017 May 1.
7
Prognostic and predictive biomarkers in breast cancer: Past, present and future.乳腺癌的预后和预测生物标志物:过去、现在和未来。
Semin Cancer Biol. 2018 Oct;52(Pt 1):56-73. doi: 10.1016/j.semcancer.2017.08.010. Epub 2017 Sep 4.
8
Hypoxia-induced angiopoietin-like protein 4 as a clinical biomarker and treatment target for human prostate cancer.缺氧诱导的血管生成素样蛋白4作为人类前列腺癌的临床生物标志物和治疗靶点
Oncol Rep. 2017 Jul;38(1):120-128. doi: 10.3892/or.2017.5669. Epub 2017 May 24.
9
The mechanism between epithelial mesenchymal transition in breast cancer and hypoxia microenvironment.乳腺癌上皮间质转化与缺氧微环境的关系机制。
Biomed Pharmacother. 2016 May;80:393-405. doi: 10.1016/j.biopha.2016.02.044. Epub 2016 Apr 17.
10
Significance of Tissue Expression and Serum Levels of Angiopoietin-like Protein 4 in Breast Cancer Progression: Link to NF-κB /P65 Activity and Pro-Inflammatory Cytokines.血管生成素样蛋白4的组织表达及血清水平在乳腺癌进展中的意义:与核因子κB/P65活性及促炎细胞因子的关联
Asian Pac J Cancer Prev. 2015;16(18):8579-87. doi: 10.7314/apjcp.2015.16.18.8579.